A rapid genotyping method for the vivax malaria transmission-blocking vaccine candidates, Pvs25 and Pvs28

Parasitology International

Volumn 53, Issue 3, 2004, Pages 211-216

  Tsuboi, Takafumi ^a,b   Kaneko, Osamu ^a   Cao, Ya Ming ^a,c   Tachibana, Mayumi ^a   Yakushijin, Yoshihiro ^a   Nagao, Takayoshi ^d   Kanbara, Hiroji ^d   Torii, Motomi ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY   (Japan)

^c CHINA MEDICAL UNIVERSITY   (China)

^d NAGASAKI UNIVERSITY   (Japan)

Author keywords

Malaria; Ookinete; PCR, polymerase chain reaction; Plasmodium vivax; Polymorphism; SSCP, single strand conformational polymorphism; Transmission blocking vaccine

Indexed keywords

MALARIA VACCINE; NUCLEOTIDE; PARASITE ANTIGEN; PVS25 ANTIGEN; PVS28 ANTIGEN; RADIOISOTOPE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ELECTROPHORESIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; ISOTOPE LABELING; MALARIA; METHODOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE TRANSMISSION; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING TEST; SINGLE STRAND CONFORMATION POLYMORPHISM;

ANIMALS; ANTIGENS, PROTOZOAN; ANTIGENS, SURFACE; GENOTYPE; MALARIA VACCINES; MALARIA, VIVAX; MOLECULAR SEQUENCE DATA; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE ANALYSIS, DNA; TIME FACTORS;

PLASMODIUM VIVAX;

EID: 2442480696     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parint.2004.01.012     Document Type: Article

References (8)

1. Tsuboi T, Tachibana M, Kaneko O, Torii M. Transmission-blocking vaccine of vivax malaria. Parasitol Int. 52:2003;1-11
2. Kaslow D.C., Quakyi I.A., Syin C., Raum M.G., Keister D.B., Coligan J.E., et al. A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains. Nature. 333:1988;74-76
3. Duffy P.E., Kaslow D.C. A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines. Infect Immun. 65:1997;1109-1113
4. Tsuboi T., Kaslow D.C., Gozar M.M., Tachibana M., Cao Y.M., Torii M. Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates. Mol Med. 4:1998;772-782
5. Hisaeda H., Stowers A.W., Tsuboi T., Collins W.E., Sattabongkot J., Suwanabun N., et al. Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes. Infect Immun. 68:2000;6618-6623
6. Kaslow D.C., Quakyi I.A., Keister D.B. Minimal variation in a vaccine candidate from the sexual stage of Plasmodium falciparum. Mol Biochem Parasitol. 32:1989;101-103
7. Shi Y.P., Alpers M.P., Povoa M.M., Lal A.A. Single amino acid variation in the ookinete vaccine antigen from field isolates of Plasmodium falciparum. Mol Biochem Parasitol. 50:1992;179-180
8. Hafalla J.C., Santiago M.L., Pasay M.C., Ramirez B., Gozar M.M., Saul A. Minimal variation in the Pfs28 ookinete antigen from Philippine field isolates of Plasmodium falciparum. Mol Biochem Parasitol. 87:1997;97-99